Synapse - Works

Results (2146)

DB-1305 (a Trop-2 targeted antibody-drug-conjugate [ADC]) in patients (pts) with advanced solid tumors: Preliminary clinical results from the phase (Ph) I/IIa study

Meeting Abstract

Marathe, O.; Cheng, Y.; Spira, A. I.; Hamilton, E. P.; Rubinstein, M. M.; Dong, X.; Li, L.; Lv, D.; Shi, J.; Gabrail, N.; more...
Annals of Oncology (2023)

Fulltext@MSK | Save

DESTINY-PanTumor02 study of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: Exploratory biomarker analyses of HER2 expression and gene amplification in tissue and plasma

Meeting Abstract

Makker, V.; Lee, J. Y.; Oh, D. Y.; Oaknin, A.; Puvvada, S. D.; Cecchi, F.; McEwen, R.; Michelini, F.; Meric-Bernstam, F.
Annals of Oncology (2023)

Fulltext@MSK | Save

HER2 genetic intratumor heterogeneity is associated with resistance to trastuzumab and trastuzumab emtansine therapy in recurrent high-grade endometrial cancer

Journal Article

Shen, S.; Ma, W.; Brown, D.; Da Cruz Paula, A.; Zhou, Q.; Iaosonos, A.; Tessier-Cloutier, B.; Ross, D. S.; Troso-Sandoval, T.; Reis-Filho, J. S.; more...
Modern Pathology (2023)

Fulltext@MSK | Save

Tisotumab vedotin in combination with carboplatin, pembrolizumab, or bevacizumab in recurrent or metastatic cervical cancer: Results from the innovaTV 205/GOG-3024/ENGOT-cx8 study

Journal Article

Vergote, I.; Van Nieuwenhuysen, E.; O'Cearbhaill, R. E.; Westermann, A.; Lorusso, D.; Ghamande, S.; Collins, D. C.; Banerjee, S.; Mathews, C. A.; Gennigens, C.; more...
Journal of Clinical Oncology (2023)

Fulltext@MSK | Save

Synoptic reporting for pretreatment CT examination in patients with advanced ovarian cancer: Impact on documentation of disease sites and physician satisfaction

Journal Article

Andrieu, P. C.; Nikolovski, I.; Juluru, K.; Sadowski, E.; Gangai, N.; Zheng, J.; Capanu, M.; Praiss, A. M.; Nougaret, S.; Shinagare, A. B.; more...
American Journal of Roentgenology (2023)

Fulltext@MSK | Save

Modern associations of uterine carcinomas with prior exposure to tamoxifen

Meeting Abstract

Rios-Doria, E.; Hodgson, A.; Aviki, E.; Zivanovic, O.; Friedman, C.; Aghajanian, C.; Makker, V.; Liu, Y.; Zamarin, D.; Leitao, M.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Germline drivers of gynecologic carcinosarcoma

Meeting Abstract

Sia, T.; Birsoy, O.; Kemel, Y.; Maio, A.; Salo-Mullen, E.; Sheehan, M.; Hensley, M.; Rubinstein, M.; Makker, V.; Grisham, R.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Mesonephric and mesonephric-like adenocarcinomas of gynecologic origin: A single-center experience with molecular characterization, treatment, and oncologic outcomes

Meeting Abstract

Praiss, A.; Park, K.; Zhou, Q.; White, C.; Iasonos, A.; Zivanovic, O.; Abu-Rustum, N.; Weigelt, B.; Aghajanian, C.; Grisham, R.
Gynecologic Oncology (2023)

Fulltext@MSK | Save

ENGOT-EN20/GOG-3083/XPORT-EC-042 A phase 3, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients (pts) with P53 wild-type, advanced or recurrent endometrial carcinoma

Meeting Abstract

Makker, V.; Vergote, I.; Mirza, M.; Coleman, R.; Fidalgo, J. A. P.; Monk, B.; Valabrega, G.; Slomovitz, B.; van Gorp, T.; Moore, K.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save

Evolution of intra-tumoral and peripheral pro-tumorigenic response during primary cytoreductive surgery for ovarian cancer

Meeting Abstract

Praiss, A.; Moukarzel, L.; Zhu, Y.; Derakhshan, F.; Hoang, T.; Pesci, G.; Green, H.; Hanlon, E.; Gardner, G.; Roche, K. L.; more...
Gynecologic Oncology (2023)

Fulltext@MSK | Save